Literature DB >> 24983975

Predictors of abdominal pain in depressed pediatric inflammatory bowel disease patients.

Arvind I Srinath1, Alka Goyal, Lori A Zimmerman, Melissa C Newara, Margaret A Kirshner, Francis Nicole McCarthy, David Keljo, David Binion, Athos Bousvaros, David R DeMaso, Ada Youk, Eva M Szigethy.   

Abstract

BACKGROUND: Pediatric patients with inflammatory bowel disease (IBD) have high rates of abdominal pain. The study aims were to (1) evaluate biological and psychological correlates of abdominal pain in depressed youth with IBD and (2) determine predictors of abdominal pain in Crohn's disease (CD) and ulcerative colitis (UC).
METHODS: Seven hundred sixty-five patients aged 9 to 17 years with IBD seen over 3 years at 2 sites were screened for depression. Depressed youth completed comprehensive assessments for abdominal pain, psychological (depression and anxiety), and biological (IBD-related, through disease activity indices and laboratory values) realms.
RESULTS: Two hundred seventeen patients with IBD (161 CD, 56 UC) were depressed. One hundred sixty-three (120 CD, 43 UC) patients had complete abdominal pain index scores. In CD, abdominal pain was associated with depression (r = 0.33; P < 0.001), diarrhea (r = 0.34; P = 0.001), erythrocyte sedimentation rate (r = 0.22; P = 0.02), low albumin (r = 0.24; P = 0.01), weight loss (r = 0.33; P = 0.001), and abdominal tenderness (r = 0.38, P = 0.002). A multivariate model with these significant correlates represented 32% of the variance in pain. Only depression (P = 0.03), weight loss (P = 0.04), and abdominal tenderness (P = 0.01) predicted pain for patients with CD. In UC, pain was associated with depression (r = 0.46; P = 0.002) and nocturnal stools (r = 0.32; P = 0.046). In the multivariate model with these significant correlates, 23% of the variance was explained and only depression (P = 0.02) predicted pain.
CONCLUSIONS: The psychological state of pediatric patients with IBD may increase the sensitivity to abdominal pain. Thus, screening for and treating comorbid depression may prevent excessive medical testing and unnecessary escalation of IBD medications.

Entities:  

Mesh:

Year:  2014        PMID: 24983975      PMCID: PMC4369148          DOI: 10.1097/MIB.0000000000000104

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  64 in total

1.  K-SADS-PL.

Authors:  J Kaufman; B Birmaher; D A Brent; N D Ryan; U Rao
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2000-10       Impact factor: 8.829

2.  Treatment of functional diarrhea.

Authors:  Evan S Dellon; Yehuda Ringel
Journal:  Curr Treat Options Gastroenterol       Date:  2006-07

3.  A meta-analytic review of the psychosocial adjustment of youth with inflammatory bowel disease.

Authors:  Rachel Neff Greenley; Kevin A Hommel; Justin Nebel; Tara Raboin; Shun-Hwa Li; Pippa Simpson; Laura Mackner
Journal:  J Pediatr Psychol       Date:  2010-02-01

4.  The relationship of current psychiatric disorder to functional disability and distress in patients with inflammatory bowel disease.

Authors:  E A Walker; M D Gelfand; A N Gelfand; F Creed; W J Katon
Journal:  Gen Hosp Psychiatry       Date:  1996-07       Impact factor: 3.238

5.  The overlap of functional abdominal pain in pediatric Crohn's disease.

Authors:  Lori A Zimmerman; Arvind I Srinath; Alka Goyal; Athos Bousvaros; Peter Ducharme; Eva Szigethy; Samuel Nurko
Journal:  Inflamm Bowel Dis       Date:  2013 Mar-Apr       Impact factor: 5.325

6.  A prospective school-based study of abdominal pain and other common somatic complaints in children.

Authors:  Miguel Saps; Roopa Seshadri; Marcelo Sztainberg; Gilda Schaffer; Beth M Marshall; Carlo Di Lorenzo
Journal:  J Pediatr       Date:  2008-11-28       Impact factor: 4.406

7.  Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial.

Authors:  Stephen B Hanauer; Burton I Korelitz; Paul Rutgeerts; Mark A Peppercorn; Ronald A Thisted; Russell D Cohen; Daniel H Present
Journal:  Gastroenterology       Date:  2004-09       Impact factor: 22.682

8.  Axonal degeneration/necrosis: a possible ultrastructural marker for Crohn's disease.

Authors:  M M Steinhoff; I J Kodner; K DeSchryver-Kecskemeti
Journal:  Mod Pathol       Date:  1988-05       Impact factor: 7.842

9.  Pediatricians overestimate importance of physical symptoms upon children's health concerns.

Authors:  Hester J Loonen; Bert H H F Derkx; Anne M Griffiths
Journal:  Med Care       Date:  2002-10       Impact factor: 2.983

10.  "It doesn't do any harm, but patients feel better": a qualitative exploratory study on gastroenterologists' perspectives on the role of antidepressants in inflammatory bowel disease.

Authors:  Antonina A Mikocka-Walus; Deborah A Turnbull; Nicole T Moulding; Ian G Wilson; Jane M Andrews; Gerald J Holtmann
Journal:  BMC Gastroenterol       Date:  2007-09-24       Impact factor: 3.067

View more
  9 in total

1.  Psychological Distress and Quality of Life in Pediatric Crohn Disease: Impact of Pain and Disease State.

Authors:  Robyn Lewis Claar; Miranda A L van Tilburg; Bisher Abdullah; Shelby Langer; Dalia Sherif; William E Whitehead; Douglas A Drossman; Rona L Levy
Journal:  J Pediatr Gastroenterol Nutr       Date:  2017-10       Impact factor: 2.839

2.  Pain Management in Patients With Inflammatory Bowel Disease.

Authors:  Eva Szigethy
Journal:  Gastroenterol Hepatol (N Y)       Date:  2018-01

3.  Abdominal Pain and Anxious or Depressed State Are Independently Associated With Weight Loss in Inflammatory Bowel Disease.

Authors:  Venkata Subhash Gorrepati; Christopher Soriano; Ansh Johri; Shannon Dalessio; August Stuart; Walter Koltun; Andrew Tinsley; Kofi Clarke; Emmanuelle Williams; Matthew Coates
Journal:  Crohns Colitis 360       Date:  2020-06-03

Review 4.  Pediatric inflammatory bowel disease and depression: treatment implications.

Authors:  Divya Keethy; Christine Mrakotsky; Eva Szigethy
Journal:  Curr Opin Pediatr       Date:  2014-10       Impact factor: 2.856

5.  Effects of a Cognitive Behavioral Therapy Intervention Trial to Improve Disease Outcomes in Children with Inflammatory Bowel Disease.

Authors:  Rona L Levy; Miranda A L van Tilburg; Shelby L Langer; Joan M Romano; Lynn S Walker; Lloyd A Mancl; Tasha B Murphy; Robyn L Claar; Shara I Feld; Dennis L Christie; Bisher Abdullah; Melissa M DuPen; Kimberly S Swanson; Melissa D Baker; Susan A Stoner; William E Whitehead
Journal:  Inflamm Bowel Dis       Date:  2016-09       Impact factor: 5.325

6.  Effectiveness of disease-specific cognitive-behavioural therapy on depression, anxiety, quality of life and the clinical course of disease in adolescents with inflammatory bowel disease: study protocol of a multicentre randomised controlled trial (HAPPY-IBD).

Authors:  Gertrude van den Brink; Luuk Stapersma; Hanan El Marroun; Jens Henrichs; Eva M Szigethy; Elisabeth Mwj Utens; Johanna C Escher
Journal:  BMJ Open Gastroenterol       Date:  2016-03-02

7.  Simple pain measures reveal psycho-social pathology in patients with Crohn's disease.

Authors:  Shmuel Odes; Michael Friger; Ruslan Sergienko; Doron Schwartz; Orly Sarid; Vered Slonim-Nevo; Terri Singer; Elena Chernin; Hillel Vardi; Dan Greenberg
Journal:  World J Gastroenterol       Date:  2017-02-14       Impact factor: 5.742

8.  Pain Severity and Vitamin D Deficiency in IBD Patients.

Authors:  Svein Oskar Frigstad; Marte Lie Høivik; Jørgen Jahnsen; Milada Cvancarova; Tore Grimstad; Ingrid Prytz Berset; Gert Huppertz-Hauss; Øistein Hovde; Tomm Bernklev; Bjørn Moum; Lars-Petter Jelsness-Jørgensen
Journal:  Nutrients       Date:  2019-12-20       Impact factor: 5.717

9.  Trends in US emergency department visits and subsequent hospital admission among patients with inflammatory bowel disease presenting with abdominal pain: a real-world study from a national emergency department sample database.

Authors:  Zhijie Ding; Aarti Patel; James Izanec; Christopher D Pericone; Jennifer H Lin; Christopher W Baugh
Journal:  J Mark Access Health Policy       Date:  2021-04-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.